Sunitinib is effective and tolerable in Chinese patients with advanced pancreatic neuroendocrine tumors: a multicenter retrospective study in China
Crossref DOI link: https://doi.org/10.1007/s00280-017-3367-9
Published Online: 2017-07-13
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Yuhong
Jin, Kaizhou
Tan, Huangying
Zhang, Pan
Yang, Qiuchen
Wang, Wei
Li, Jie
Shao, Chenghao
Xue, Ling
Feng, Shiting
Chen, Minhu
Yu, Xianjun
Chen, Jie
License valid from 2017-07-13